24-hour wearable blood pressure monitoring comparison
Official title: Wearable Evaluation of Ambulatory Readings for Blood Pressure
Run by Beth Israel Deaconess Medical Center · NCT06610448 · Data updated 2026-11-12
We will test if wearable cuffless and cuff-based devices can reliably measure blood pressure over 24 hours compared with a standard ambulatory cuff monitor in adults with normal or high blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Beth Israel Deaconess Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | June 6, 2025 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | June 11, 2026 |
| Trial ID | NCT06610448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–100 who live in the Boston area, can provide informed consent, have two arms, and can tolerate wearing multiple BP devices for 24 hours are ideal candidates.
✕Probably not a fit
People with arm circumferences over 50 cm, those unable to wear the devices or complete the procedures, or those who cannot travel to Boston for study visits are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults from the Boston area will wear multiple blood pressure and activity monitors for two consecutive days to compare novel cuffless and wrist-based devices with a Spacelabs ambulatory cuff monitor. Up to 250 participants (at least 100) will each wear up to seven devices, with device assignment randomized by day and by the arm or wrist on which devices are worn. On the first visit participants are fitted with three BP devices (including Spacelabs ABPM or ABPMpro, the Aktiia wristband, and a cuff-based wrist monitor) plus an activity monitor, and on the second visit they wear a different set including a chest patch ABPM. Continuous 24-hour recordings including overnight data will be collected and compared to determine device accuracy across daily activities and positions.
Why it matters
Potential benefit: If successful, accurate cuffless wearables could make 24-hour blood pressure monitoring easier and more widely available, improving diagnosis and management of hypertension.
How similar studies have gone: Previous work on cuffless and wrist blood pressure monitors has produced mixed results, with some promising devices but inconsistent validation against standard ambulatory cuff monitors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 100 years * All neighborhoods in Boston area * Be able to walk with two limbs and have two arms * Willing and able to complete required measurement procedures * Able to provide informed consent Exclusion Criteria: * Failure to receive informed consent * Arm circumference of more than 50cm
Where it's running
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Stephen P. Juraschek, MD, PhD
- Email: sjurasch@bidmc.harvard.edu
- Phone: 617-754-1416
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Baxdrostat for Uncontrolled Hypertension in Chinese Adults
This study tests whether baxdrostat 2 mg once daily can lower 24-hour systolic blood pressure in adults with uncontrolled hypertension who are already on multiple hypertension medications.
-
SAL0140 at different doses for uncontrolled hypertension
This trial tests whether SAL0140 at various doses can help people with uncontrolled high blood pressure compared to placebo.
-
Modified-release RTN-001 for adults with uncontrolled high blood pressure
This trial will test whether taking a daily modified-release RTN-001 capsule lowers blood pressure in adults whose hypertension remains uncontrolled despite at least two blood-pressure medicines.
-
Iloperidone for adults with uncontrolled high blood pressure
We are testing whether iloperidone can lower blood pressure in adults whose blood pressure stays high despite at least 8 weeks of one or more blood pressure medications.
-
SAL0140 safety and dosing in healthy Chinese adults
This project will test whether SAL0140 is safe, well tolerated, and how it is processed by the body in healthy Chinese adults to guide dosing for uncontrolled hypertension.
-
Adaptive program to reduce food insecurity for people with uncontrolled high blood pressure
This study will test whether different food-support approaches—resource information, community health worker help, or medically-tailored meals—help adults with uncontrolled hypertension who face food insecurity stick to diet and medication plans and lower their blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.